Takeda related Press Releases

PPD Confirms Takeda Receives FDA Complete Response for Alogliptin WILMINGTON, N.C. --(Business Wire)-- Jun 29, 2009 PPD, Inc. (NASDAQ: PPDI) today announced that Takeda Pharmaceutical Company Limited... Read more...

Takeda Establishes "Takeda Global Advisory Board" Posted on:24 Jun 09.Osaka, Japan, June 23, 2009 - Takeda Pharmaceutical Company Limited ("Takeda") today announced the establishment of the Takeda... Read more...

Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe Osaka, Japan, June 4, 2009 -Takeda Pharmaceutical Company Limited ("Takeda") announced today that it has reviewed the... Read more...

PPD Announces Takeda to Conduct Additional Study for Alogliptin MAA in the EU Takeda to postpone MAA submissions for alogliptin and alogliptin/ACTOS WILMINGTON, N.C. (June 3, 2009) - PPD, Inc.... Read more...

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise OSAKA, Japan, and IRVINE, Calif., May 18... Read more...

Takeda Expands its Own Sales and Marketing Operations in Europe Osaka, Japan & London, United Kingdom, March 30, 2009 - Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and its

... Read more...

Takeda to Create Global Centers of Excellence OSAKA, Japan, March 30, 2009 /PRNewswire via COMTEX/ ----Takeda Pharmaceutical Company Limited ("Takeda") today announced a reorganization of its

... Read more...

PPD Updates Discovery Segment Guidance Regarding Alogliptin WILMINGTON, N.C. (March 6, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced that Takeda Pharmaceutical Company Limited issued a news

... Read more...

Takeda Pharmaceutical Co. Ltd. Says FDA Needs More Data on Key Diabetes Drug OSAKA, Japan, March 6 /PRNewswire/ -- Takeda Pharmaceutical Company Limited today announced that Takeda Global Research

... Read more...

FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout First new treatment option in more than 40 years, marking second FDA approval for Takeda within... Read more...